Reviewed,
UniProtKB/Swiss-Prot P01133 (EGF_HUMAN)
Last modified
February 9, 2010.
Version 120.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Pro-epidermal growth factor Short name=EGF Cleaved into the following chain: 1- Recommended name: Epidermal growth factor Alternative name(s): Urogastrone | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1207 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6. Ref.7 |
| Subcellular location | |
| Tissue specificity | Expressed in kidney, salivary gland, cerebrum and prostate. Ref.7 |
| Involvement in disease | Defects in EGF are the cause of hypomagnesemia type 4 (HOMG4) [MIM:611718]; also known as renal hypomagnesemia normocalciuric. HOMG4 is a disorder characterized by massive renal hypomagnesemia and normal levels of serum calcium and calcium excretion. Clinical features include seizures, mild-to mederate psychomotor retardation, and brisk tendon reflexes. Ref.7 |
| Sequence similarities | Contains 9 EGF-like domains. Contains 9 LDL-receptor class B repeats. |
| Sequence caution | The sequence AAR84237.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||
Molecule processing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 22 | 22 | Potential | ||||||||||||||||
| Chain | 23 – 1207 | 1185 | Pro-epidermal growth factor | PRO_0000007540 | |||||||||||||||
| Chain | 971 – 1023 | 53 | Epidermal growth factor | PRO_0000007541 | |||||||||||||||
Regions | |||||||||||||||||||
| Topological domain | 23 – 1032 | 1010 | Extracellular Potential | ||||||||||||||||
| Transmembrane | 1033 – 1053 | 21 | Potential | ||||||||||||||||
| Topological domain | 1054 – 1207 | 154 | Cytoplasmic Potential | ||||||||||||||||
| Repeat | 86 – 127 | 42 | LDL-receptor class B 1 | ||||||||||||||||
| Repeat | 128 – 169 | 42 | LDL-receptor class B 2 | ||||||||||||||||
| Repeat | 170 – 211 | 42 | LDL-receptor class B 3 | ||||||||||||||||
| Repeat | 212 – 258 | 47 | LDL-receptor class B 4 | ||||||||||||||||
| Domain | 314 – 355 | 42 | EGF-like 1 | ||||||||||||||||
| Domain | 356 – 396 | 41 | EGF-like 2; calcium-binding Potential | ||||||||||||||||
| Domain | 397 – 437 | 41 | EGF-like 3 | ||||||||||||||||
| Domain | 435 – 477 | 43 | EGF-like 4 | ||||||||||||||||
| Repeat | 483 – 523 | 41 | LDL-receptor class B 5 | ||||||||||||||||
| Repeat | 524 – 566 | 43 | LDL-receptor class B 6 | ||||||||||||||||
| Repeat | 567 – 609 | 43 | LDL-receptor class B 7 | ||||||||||||||||
| Repeat | 610 – 653 | 44 | LDL-receptor class B 8 | ||||||||||||||||
| Repeat | 654 – 696 | 43 | LDL-receptor class B 9 | ||||||||||||||||
| Domain | 741 – 781 | 41 | EGF-like 5 | ||||||||||||||||
| Domain | 831 – 869 | 39 | EGF-like 6 | ||||||||||||||||
| Domain | 870 – 911 | 42 | EGF-like 7; calcium-binding Potential | ||||||||||||||||
| Domain | 912 – 952 | 41 | EGF-like 8; calcium-binding Potential | ||||||||||||||||
| Domain | 972 – 1013 | 42 | EGF-like 9 | ||||||||||||||||
Amino acid modifications | |||||||||||||||||||
| Glycosylation | 38 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 104 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 117 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 148 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 324 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 404 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 596 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 815 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Glycosylation | 926 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||
| Disulfide bond | 318 ↔ 330 | By similarity | |||||||||||||||||
| Disulfide bond | 325 ↔ 339 | By similarity | |||||||||||||||||
| Disulfide bond | 341 ↔ 354 | By similarity | |||||||||||||||||
| Disulfide bond | 360 ↔ 371 | By similarity | |||||||||||||||||
| Disulfide bond | 367 ↔ 380 | By similarity | |||||||||||||||||
| Disulfide bond | 382 ↔ 395 | By similarity | |||||||||||||||||
| Disulfide bond | 401 ↔ 412 | By similarity | |||||||||||||||||
| Disulfide bond | 408 ↔ 421 | By similarity | |||||||||||||||||
| Disulfide bond | 423 ↔ 436 | By similarity | |||||||||||||||||
| Disulfide bond | 439 ↔ 451 | By similarity | |||||||||||||||||
| Disulfide bond | 447 ↔ 461 | By similarity | |||||||||||||||||
| Disulfide bond | 463 ↔ 476 | By similarity | |||||||||||||||||
| Disulfide bond | 745 ↔ 756 | By similarity | |||||||||||||||||
| Disulfide bond | 752 ↔ 765 | By similarity | |||||||||||||||||
| Disulfide bond | 767 ↔ 780 | By similarity | |||||||||||||||||
| Disulfide bond | 835 ↔ 846 | By similarity | |||||||||||||||||
| Disulfide bond | 840 ↔ 855 | By similarity | |||||||||||||||||
| Disulfide bond | 857 ↔ 868 | By similarity | |||||||||||||||||
| Disulfide bond | 874 ↔ 888 | By similarity | |||||||||||||||||
| Disulfide bond | 881 ↔ 897 | By similarity | |||||||||||||||||
| Disulfide bond | 899 ↔ 910 | By similarity | |||||||||||||||||
| Disulfide bond | 916 ↔ 929 | By similarity | |||||||||||||||||
| Disulfide bond | 923 ↔ 938 | By similarity | |||||||||||||||||
| Disulfide bond | 940 ↔ 951 | By similarity | |||||||||||||||||
| Disulfide bond | 976 ↔ 990 | ||||||||||||||||||
| Disulfide bond | 984 ↔ 1001 | ||||||||||||||||||
| Disulfide bond | 1003 ↔ 1012 | ||||||||||||||||||
Natural variations | |||||||||||||||||||
| Natural variant | 16 | 1 | S → R: dbSNP rs11568849. Ref.2 | VAR_020161 | |||||||||||||||
| Natural variant | 151 | 1 | H → Y: dbSNP rs9991664. | VAR_033825 | |||||||||||||||
| Natural variant | 257 | 1 | D → H: dbSNP rs11568911. Ref.2 | VAR_020968 | |||||||||||||||
| Natural variant | 292 | 1 | L → H: dbSNP rs35191533. | VAR_033826 | |||||||||||||||
| Natural variant | 431 | 1 | R → K: dbSNP rs11568943. Ref.2 | VAR_020162 | |||||||||||||||
| Natural variant | 638 | 1 | S → R: dbSNP rs11568992. Ref.2 | VAR_020969 | |||||||||||||||
| Natural variant | 708 | 1 | M → I: dbSNP rs2237051. Ref.2 | VAR_002275 | |||||||||||||||
| Natural variant | 723 | 1 | G → R: dbSNP rs6413481. | VAR_020163 | |||||||||||||||
| Natural variant | 784 | 1 | D → V: dbSNP rs11569017. Ref.2 | VAR_020164 | |||||||||||||||
| Natural variant | 842 | 1 | M → T: dbSNP rs11569046. Ref.2 | VAR_020165 | |||||||||||||||
| Natural variant | 920 | 1 | E → V: dbSNP rs4698803. Ref.2 | VAR_020970 | |||||||||||||||
| Natural variant | 981 | 1 | D → E: dbSNP rs11569086. Ref.2 | VAR_020971 | |||||||||||||||
| Natural variant | 1043 | 1 | L → F: dbSNP rs11569098. Ref.2 | VAR_020166 | |||||||||||||||
| Natural variant | 1070 | 1 | P → L in HOMG4; affects basolateral sorting of pro-EGF preventing the hormone to stimulate EGFR; lack of TRPM6 activation. Ref.7 | VAR_039474 | |||||||||||||||
| Natural variant | 1084 | 1 | A → G: dbSNP rs11569111. Ref.2 | VAR_020972 | |||||||||||||||
Secondary structure | |||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||
| Turn | 979 – 982 | 4 | |||||||||||||||||
| Beta strand | 989 – 992 | 4 | |||||||||||||||||
| Helix | 994 – 996 | 3 | |||||||||||||||||
| Beta strand | 999 – 1003 | 5 | |||||||||||||||||
| Beta strand | 1007 – 1009 | 3 | |||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization." Bell G.I., Fong N.M., Stempien M.M., Wormsted M.A., Caput D., Ku L., Urdea M.S., Rall L.B., Sanchez-Pescador R. Nucleic Acids Res. 14:8427-8446(1986) [PubMed: 3491360] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Kidney. |
| [2] | NIEHS SNPs program Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ARG-16; HIS-257; LYS-431; ARG-638; ILE-708; VAL-784; THR-842; VAL-920; GLU-981; PHE-1043 AND GLY-1084. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Colon. |
| [4] | "The primary structure of human urogastrone." Gregory H., Preston B.M. Int. J. Pept. Protein Res. 9:107-118(1977) [PubMed: 300079] [Abstract] Cited for: PROTEIN SEQUENCE OF 971-1023. |
| [5] | "The primary structure of human EGF produced by genetic engineering, studied by high-performance tandem mass spectrometry." Furuya M., Akashi S., Hirayama K. Biochem. Biophys. Res. Commun. 163:1100-1106(1989) [PubMed: 2789514] [Abstract] Cited for: PROTEIN SEQUENCE OF 971-1023. |
| [6] | "Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha." Hommel U., Harvey T.S., Driscoll P.C., Campbell I.D. J. Mol. Biol. 227:271-282(1992) [PubMed: 1522591] [Abstract] Cited for: STRUCTURE BY NMR OF EGF. |
| [7] | "Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia." Groenestege W.M.T., Thebault S., van der Wijst J., van den Berg D., Janssen R., Tejpar S., van den Heuvel L.P., van Cutsem E., Hoenderop J.G., Knoers N.V., Bindels R.J. J. Clin. Invest. 117:2260-2267(2007) [PubMed: 17671655] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, VARIANT HOMG4 LEU-1070, CHARACTERIZATION OF VARIANT HOMG4 LEU-1070. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X04571 mRNA. Translation: CAA28240.1. AY506357 Genomic DNA. Translation: AAR84237.1. Sequence problems. BC093731 mRNA. Translation: AAH93731.1. BC113461 mRNA. Translation: AAI13462.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00000073. | ||||||||||||||||||||||||||||||
| PIR | EGHU. A25531. | ||||||||||||||||||||||||||||||
| RefSeq | NP_001954.2. | ||||||||||||||||||||||||||||||
| UniGene | Hs.419815 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| DIP | DIP-5767N. | ||||||||||||||||||||||||||||||
| IntAct | P01133. 1 interaction. | ||||||||||||||||||||||||||||||
| STRING | P01133. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P01133. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PRIDE | P01133. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000265171; ENSP00000265171; ENSG00000138798; Homo sapiens. [Genome view] | ||||||||||||||||||||||||||||||
| GeneID | 1950. | ||||||||||||||||||||||||||||||
| KEGG | hsa:1950. | ||||||||||||||||||||||||||||||
| UCSC | uc003hzy.2. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 1950. | ||||||||||||||||||||||||||||||
| GeneCards | GC04P111104. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0031420. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:3229. EGF. | ||||||||||||||||||||||||||||||
| HPA | CAB017843. | ||||||||||||||||||||||||||||||
| MIM | 131530. gene. 611718. phenotype. | ||||||||||||||||||||||||||||||
| PharmGKB | PA27664. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | prNOG06050. | ||||||||||||||||||||||||||||||
| HOGENOM | HBG279909. | ||||||||||||||||||||||||||||||
| HOVERGEN | P01133. | ||||||||||||||||||||||||||||||
| InParanoid | P01133. | ||||||||||||||||||||||||||||||
| OMA | ANSQDIR. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG9T7BPR. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | a6b1_a6b4_integrin_pathway. a6b1 and a6b4 Integrin signaling. arf6cyclingpathway. Arf6 signaling events. ceramidepathway. Ceramide signaling pathway. endothelinpathway. Endothelins. telomerasepathway. Regulation of Telomerase. ptp1bpathway. Signaling events mediated by PTP1B. txa2pathway. Thromboxane A2 receptor signaling. | ||||||||||||||||||||||||||||||
| Reactome | REACT_604. Hemostasis. REACT_9417. Signaling by EGFR. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P01133. | ||||||||||||||||||||||||||||||
| Bgee | P01133. | ||||||||||||||||||||||||||||||
| CleanEx | HS_EGF. | ||||||||||||||||||||||||||||||
| Genevestigator | P01133. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR011042. 6-blade_b-propeller_TolB-like. IPR006210. EGF-like. IPR013032. EGF-like_reg_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR001336. EGF_1. IPR000742. EGF_3. IPR001881. EGF_Ca_bd. IPR013091. EGF_Ca_bd_2. IPR018097. EGF_Ca_bd_CS. IPR000033. LDL_rcpt_classB_YWTD_rpt. IPR016317. Pro-epidermal_GF. [Graphical view] | ||||||||||||||||||||||||||||||
| Gene3D | G3DSA:2.120.10.30. 6-blade_b-propeller_TolB-like. 2 hits. | ||||||||||||||||||||||||||||||
| Pfam | PF07645. EGF_CA. 3 hits. PF00058. Ldl_recept_b. 4 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| PIRSF | PIRSF001778. Pro-epidermal_growth_factor. 1 hit. | ||||||||||||||||||||||||||||||
| PRINTS | PR00009. EGFTGF. | ||||||||||||||||||||||||||||||
| SMART | SM00181. EGF. 6 hits. SM00179. EGF_CA. 2 hits. SM00135. LY. 9 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS00010. ASX_HYDROXYL. 3 hits. PS00022. EGF_1. 1 hit. PS01186. EGF_2. 7 hits. PS50026. EGF_3. 5 hits. PS01187. EGF_CA. 3 hits. PS51120. LDLRB. 9 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||
| DrugBank | DB00605. Sulindac. | ||||||||||||||||||||||||||||||
| NextBio | 7903. | ||||||||||||||||||||||||||||||
| PMAP-CutDB | P01133. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | EGF_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P01133 Secondary accession number(s): Q52LZ6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


